EVOS M7000 Imaging System

The National Institutes of Health, under the Department of Health and Human Services, intends to award a sole-source Firm-Fixed-Price Purchase Order to Life Technologies Corp. for the EVOS M7000 Imaging System under Solicitation Number 75N98026Q00276. The acquisition is justified under FAR 6.302-1 as the only responsible source capable of meeting the technical requirements for automating high-efficiency fluorescence and transmitted light imaging of tumor lesions in mouse organs, supporting tumor dormancy research at the NCI/CCR/LCBG in Bethesda, Maryland. The system must include a 5-position objective turret, four-color LED excitation channels, dual cameras, an automated X/Y stage, and advanced autofocus to enable multi-well plate imaging and time-lapse experiments, producing publication-quality images with minimal user intervention. The notice was posted on April 29, 2026, with a response deadline of May 9, 2026, and an anticipated award date of approximately May 4, 2026. Delivery and performance are expected at the NIH facility in Bethesda, MD, 20892, and submissions of capability statements must be emailed to [email hidden]. No competitive bidding is solicited, and the acquisition does not follow a Lowest Price Technically Acceptable or trade-off process. Although a $15,000 trade-in discount is mentioned for an old AMF5000 model, no formal contract value, CLINs, pricing details, packaging specifications, inspection criteria, or delivery schedule are provided. The document is a Notice of Intent and contains no formal contract clauses, evaluation factors, representations, certifications, or special requirements beyond the sole-source justification and submission instructions. Small business participation is encouraged but not required.